Sansure Biotech Inc. (SHA:688289)
15.07
+0.08 (0.53%)
Jul 13, 2026, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 8.66 billion as of July 13, 2026. Its market cap has decreased by -25.60% in one year.
Market Cap
8.66B
Enterprise Value
5.99B
Revenue
1.60B
Ranking
n/a
PE Ratio
57.35
Stock Price
15.07
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 8.66B, a decrease of -81.34%. That is a compound annual growth rate of -24.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 8.66B | -20.21% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qingdao NovelBeam Technology | 10.45B |
| Autek China | 9.44B |
| Tofflon Science and Technology Group | 8.49B |
| Aidite (Qinhuangdao) Technology | 8.37B |
| Eyebright Medical Technology (Beijing) | 8.01B |
| Tinavi Medical Technologies | 7.85B |
| Truking Technology | 5.80B |
| Mingyue Optical Lens | 5.77B |